The JADPRO Live 2021 conference for advanced practitioners in oncology was held virtually from October 7 through 17. Attendees were able to earn up to a whopping 31.25 credits from the comfort of their home or work. For those of you who were able to attend, I hope you enjoyed the sessions and the interactive format. If you were unable to attend the live conference, on-demand access will remain available through December 31.
Personally, I found the discussions during the sessions so interesting, such as the opening panel led by R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, Innovations Worth Keeping: Positive Practice Changes After the COVID-19 Pandemic, and the CE sessions Clinically Relevant Drug Interactions in the Cancer Setting and Cardio-Oncology Considerations in Oncologic Treatment Decisions. The keynote, which was titled Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity Transformation, was particularly inspiring. I look forward to returning to other sessions that I missed.
A well-deserved, special recognition of efforts in coordinating this year's conference goes to the conference chair and an esteemed colleague, Dr. Harvey. I have known Dr. Harvey for many years through our mutual interest in the care of patients with blood disorders. He practices at the top of his scope at Winship Cancer Institute of Emory University as Director of the Phase I Clinical Trials Program and Medical Director of the Clinical Trials office. He exemplifies collaborative practice in his management of patients and ongoing education of himself and others.
We are honored to work with Dr. Harvey through the various activities of JADPRO and APSHO. Dr. Harvey and the planning committee certainly went above and beyond in their efforts to successfully mirror a live, in-person conference and to provide interactive and innovative learning opportunities.
Here are some conference statistics that I found interesting:
There were 1,199 registered attendees, with the top 5 states represented being New York, Texas, California, Florida, and North Carolina.
Attendees joined by desktop (71%), mobile (26%), and tablet (3%)
There were 407 average views per clinical poster
#JADPROLive was used 343 times on Twitter, 160 times on Facebook, 54 times on Linked-In, and 51 times on Instagram
79 attendees participated in Braindates, which were knowledge-sharing conversations on participant-driven topics
There were numerous sessions, product theaters, posters, wellness activities, and other features to engage with in the digital platform. Through ttihe conference evaluation, participants were asked, “What did you like most about the JADPRO Live virtual meeting?” Aside from on-demand access, attendees appreciated the sleek platform, state-of-the-art technology, supportive staff, and high level of expertise shared by speakers. The opportunities for networking through Micro-Community Meet Ups and Conversation Circles were also regarded as an important part of the experience by respondents. Most participants reported remaining engaged throughout the presentations. Others were excited to learn of a virtual component to next year's conference, which will be a hybrid event in Aurora, Colorado.
IN THIS ISSUE
The last issue of this year is full of interesting articles to pique your interest. We have two articles in Research and Scholarship. First, Baer, along with her colleagues, share their experiences in the development and implementation of an advanced practitioner–led survivorship clinic for patients after allogeneic transplant. Albert and colleagues detail the results of their project to assess oncology provider knowledge and cardiovascular screening practices, and highlight the importance of early screening.
Two excellent Review articles provide valuable and practical information for advanced practitioners. First, Clemmons and colleagues focus on premedications for cancer therapies, while Yajima and colleagues address telehealth interventions for recognizing and managing treatment-related symptoms in patients with hematologic malignancies.
In Grand Rounds, Spicer discusses an unusual presentation of a rare cancer, retroperitoneal liposarcoma. In a Practice Matters article that I found timely and interesting, Mayden discusses improving health equity and the role of the oncology advanced practitioner in managing implicit bias. This is such a difficult topic to tackle, yet one that every reader can relate to on some level.
In addition to these and other informative articles, you will also find the abstracts from our JADPRO Live 2021 meeting as well as a recognition of the efforts of our JADPRO peer reviewers. This journal is sustained heavily by the knowledge and expertise of this excellent group of peer reviewers.
Finally, I want to thank each and every one of you for choosing to be a part of and engaging in this JADPRO and APSHO community. I wish health and happiness for you and yours in the coming year.